Endoscopic versus conservative management of iron-deficiency anemia in patients on blood thinners
Official title: A Pilot Study Evaluating the Benefit of Endoscopic Assessment for Iron Deficiency Anemia in Patients Receiving Antithrombotic Therapy
Run by Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec · NCT07089030 · Data updated 2026-11-12
This trial will test whether a conservative medical approach with limited testing works as well as repeated endoscopic exams for people on blood thinners who have recurrent iron-deficiency anemia from obscure gastrointestinal bleeding.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 90 Years |
| Sex | All |
| Enrollment | 20 (estimated) |
| Sponsor | Centre intégré universitaire de santé et de services sociaux de la Mauricie-et-du-Centre-du-Québec Academic / other |
| Locations | 1 site (Trois-Rivières, Quebec) |
| Status | Recruiting |
| Started | June 6, 2023 |
| Main results expected | June 6, 2026 |
| Study ends | June 6, 2026 |
| Registry record updated | July 28, 2025 |
| Trial ID | NCT07089030 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults on anticoagulant or antiplatelet therapy with laboratory-confirmed iron-deficiency anemia, prior negative upper/lower endoscopy and capsule endoscopy within six months, who can read French and provide informed consent are ideal candidates.
✕Probably not a fit
Patients with ongoing overt gastrointestinal bleeding, recent acute cardiac or neurological events, pregnancy, known GI or hematologic malignancy, contraindications to capsule endoscopy, or prior major small-bowel surgery are unlikely to benefit from this protocol.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center, randomized pilot assigns about 20 adults on anticoagulant or antiplatelet therapy with obscure GI bleeding to either repeated endoscopic evaluations as needed or a conservative approach with a single evaluation and regular lab monitoring. Participants in both arms receive iron supplementation or transfusions as clinically required. The primary goal is to determine feasibility and safety to inform a larger randomized trial, and a secondary goal is to compare quality of life between the approaches. The study requires prior negative EGD, colonoscopy, and capsule endoscopy within six months and French language ability for consent and follow-up.
Why it matters
Potential benefit: If successful, this approach could reduce the number of repeated invasive endoscopies and their risks for patients on antithrombotic therapy while maintaining clinical outcomes.
How similar studies have gone: There is limited randomized evidence directly comparing conservative monitoring to repeated endoscopic evaluation in this specific population, so this pilot is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Adult men and postmenopausal women with iron deficiency anemia, and premenopausal women with iron deficiency anemia and a negative gynecological evaluation; a. Laboratory-confirmed iron deficiency anemia (hemoglobin \< 120 g/L for women, \< 130 g/L for men, and ferritin \< 30 ng/L); 2. Patients receiving anticoagulant or antiplatelet therapy 3. Negative esophagogastroduodenoscopy (EGD), colonoscopy, and capsule endoscopy for gastrointestinal bleeding within six months prior to study enrollment 4. Willing and able to provide written informed consent 5. Able to read and understand French Exclusion Criteria: 1. Ongoing overt gastrointestinal bleeding 2. Acute coronary syndrome, acute neurological event, sepsis, or respiratory failure within the past week 3. Pregnant women 4. Known gastrointestinal or hematological malignancy 5. Contraindications to capsule endoscopy 6. History of bariatric surgery, gastrectomy, or segmental resection of the small intestine 7. Inability to take oral iron 8. Other sources of blood loss (e.g., urinary, gynecological, hematoma, hemolysis)
Where it's running
-
Centre hospitalier affilié universitaire régional de Trois-Rivières
Trois-Rivières, Quebec, Canada Recruiting
Study contacts
- Study coordinator: Marie-Claude Lehoux, Master
- Email: marie-claude.lehoux@ssss.gouv.qc.ca
- Phone: 819 697-3333
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Iron treatment for children and young adults with Crohn’s disease and iron deficiency anemia
This study tests how different iron treatment approaches work for kids and young adults with Crohn’s disease and iron deficiency anemia.
-
Donor Breast Milk with Early Iron Supplementation in Very Preterm Infants
In very preterm babies who mainly receive donor breast milk, this study tests whether starting iron supplementation earlier (around when feeding reaches 80 ml/kg/day) can raise ferritin and hematocrit levels by days 14 and 28.
-
Preconception versus early-pregnancy iron screening and treatment
This trial tests whether screening and treating iron deficiency before conception is better than starting screening and iron treatment in early pregnancy for preventing iron deficiency anemia later in pregnancy.
-
Ferric derisomaltose injection in adults with iron deficiency anemia under fasting conditions
This study tests whether a ferric derisomaltose injection given to adults with iron deficiency anemia in a fasting state works similarly to a reference product and is safe to use.
-
FACE-APPS approach to improve iron in adolescent girls in marginalized communities
This study tests a blended program of face-to-face counseling and mobile app activities to see if it improves iron levels in adolescent girls with iron deficiency.
-
Acupoint TENS vs. Resistance Training for Iron Deficiency Anemia in Women
This trial tests whether acupoint transcutaneous electrical nerve stimulation (Acu-TENS) or resistance exercise, in addition to standard care, can raise hemoglobin levels in women with iron deficiency anemia.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.